Optimizing the tolerability of intravenous oncolytic viral immunotherapy administration: investigation of a low-high-high dose schedule of enadenotucirev (EnAd) administration

enadenotucirev (ColoAd1) - PsiOxus

Opdivo (nivolumab) - Ono Pharma, BMS

paclitaxel - generics

Hilary McElwaine-Johnn; Sam Illingworth; Rochelle Lear; Richard Brown; Brian Champion

Apr 5, 2019